Stay updated on Crenolanib in D842V GIST: Clinical Trial
Sign up to get notified when there's something new on the Crenolanib in D842V GIST: Clinical Trial page.

Latest updates to the Crenolanib in D842V GIST: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded a centralized Locations section with state entries (California, Florida, North Carolina, Oregon, Pennsylvania, Texas) and removed the prior separate state location blocks. Updated revision to v3.3.3.SummaryDifference0.7%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 in the page metadata.SummaryDifference0.1%

- Check38 days agoChange DetectedSite revision updated from v3.2.0 to v3.3.1; no changes to study content, eligibility criteria, or results are visible on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedThe funding/operating-status notice was removed. The study details, eligibility criteria, and locations remain unchanged.SummaryDifference0.4%

- Check59 days agoChange DetectedNo additions or deletions detected. The page content and layout appear unchanged compared with the previous screenshot.SummaryDifference0.3%

- Check88 days agoChange DetectedAdded a government funding notice and an updated software version (v3.2.0), removing the old v3.1.0; this primarily updates the page’s operating status guidance and versioning.SummaryDifference5%

Stay in the know with updates to Crenolanib in D842V GIST: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crenolanib in D842V GIST: Clinical Trial page.